Market Cap (In KRW)
153.96 Billion
Revenue (In KRW)
-
Net Income (In KRW)
-35.32 Billion
Avg. Volume
216.34 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4000.0-17240.0
- PE
- -
- EPS
- -
- Beta Value
- 0.783508
- ISIN
- KR7235980000
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Seong-Jin Kim
- Employee Count
- -
- Website
- http://www.medpacto.com
- Ipo Date
- 2019-12-19
- Details
- MedPacto, Inc., a drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea. The company is developing ME-1601mAb that targets BSP1 for cancers; MS-1601A that targets TRG1 for cancers and autoimmune diseases; and vactosertib for solid tumors. MedPacto, Inc. is based in Seoul, South Korea.
More Stocks
-
DANUBEDanube Industries Limited
DANUBE
-
2683
-
SOARVolato Group, Inc.
SOAR
-
POAI
-
SHETRShetron Limited
SHETR
-
FLORATXFLORA TEXTILES LTD.
FLORATX
-
DVNCF
-
BTOC